Yu-Waye Chu - Jul 19, 2023 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Yu-Waye Chu
Stock symbol
CTMX
Transactions as of
Jul 19, 2023
Transactions value $
$0
Form type
4
Date filed
7/20/2023, 05:18 PM
Previous filing
Apr 19, 2023
Next filing
Jan 19, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTMX Stock Option (Right to Buy) Award $0 +375K $0.00 375K Jul 19, 2023 Common Stock 375K $1.82 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vest on the one year anniversary measured from July 19, 2023 (the "Vesting Commencement Date"), and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.